Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Pharmacology|October 23, 2024
Evaluating the impact of loperamide on irinotecan-induced adverse events: a disproportionality analysis of data from the World Health Organization pharmacovigilance database (VigiBase)Tomoaki Akagi, Hirofumi Hamano, Hirotaka Miyamoto, et al.
Frontiers in Pharmacology|December 17, 2024
Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase databaseYusuke Igawa, Hirofumi Hamano, Satoru Esumi, et al.
British Journal of Clinical Pharmacology|May 9, 2025
Comprehensive analysis of adverse event profile changes with pertuzumab addition to trastuzumab-based breast cancer therapy: Disproportionality analysis using VigiBaseTatsuaki Takeda, Jun Matsumoto, Tomonori Sakai, et al.
British Journal of Clinical Pharmacology|November 22, 2023
Influence of vasopressin receptor antagonists on triple-whammy acute kidney injury: A VigiBase analysisSatoru Mitsuboshi, Kenji Hayakawa, Hirofumi Hamano, et al.
Biological & Pharmaceutical Bulletin|July 4, 2014
Differential combined effect of COX inhibitors on cell survival suppressed by sorafenib in the HepG2 cell lineKenta Yagi, Yoichi Kawasaki, Hiroko Nakamura, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 12, 2025
Trends in nontuberculous mycobacterial disease mortality based on 2000-2022 data from 83 countriesKo Harada, Quynh Thi Vu, Yoshito Nishimura, et al.
International Journal of Clinical Pharmacy|January 19, 2024
A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databasesTatsuaki Takeda, Shiho Sugimoto, Jun Matsumoto, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 28, 2025
Global Trends in Clostridioides difficile Infection-related Mortality, 2001-2023: An Observational StudyHideharu Hagiya, Yoshito Nishimura, Ko Harada, et al.
Leukemia Research|April 19, 2026
Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBaseJun Matsumoto, Tatsuaki Takeda, Shiho Sugimoto, et al.
European Urology Focus|August 1, 2022
Adverse Events of Axitinib plus Pembrolizumab Versus Lenvatinib plus Pembrolizumab: A Pharmacovigilance Study in Food and Drug Administration Adverse Event Reporting SystemJun Matsumoto, Naohiro Iwata, Shogo Watari, et al.
Pageof 3